Phase II clinical trial data presented on topical alprostadil.
Publication: OBGYN & Reproduction Week
Publication Date: 22-NOV-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 NOV 22 - (NewsRx.com & NewsRx.net) -- Vivus Inc. (Nasdaq:VVUS) investigators presented positive results of a Phase II clinical study evaluating the safety and efficacy of the company's product Alista (topical alprostadil) for the treatment of female sexual arousal disorder (FSAD) in premenopausal women.
The data were reported at the Annual Meeting of the International Society for the Study of Women's Sexual Health (ISSWSH). Stephanie Kuffel, PhD,...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
